BioWorld

April 30, 2007

View Archived Issues

ArQule Partners ARQ 197 In Asia In Potential $123M Collaboration

ArQule Inc. entered a partnership on the lead program from its Cancer Survival Protein modulation program, a deal worth up to $123 million with Kyowa Hakko Kogyo Co. Ltd. (BioWorld Today) Read More

Pharmasset Prices IPO Lower Than Expected To Raise $45M

Read More

Novel Resistance Mechanism To Iressa, Tarceva Discovered

Read More

Hollis-Eden Trims Work Force To Focus On Hormone Bids

Read More

Project BioShield Moves Ahead With New Guidelines, and Boss

Read More

Alexza Bringing In $61M To Support Aerosol Drug Pipeline

Read More

Clinic Roundup

Read More

Other News To Note

Read More